GeneCopoeia OncoSpot Cancer Cell Lines
GeneCopoeia offers premade cancer cell lines carrying diverse gene mutations commonly seen in tumour biomarkers, including EGFR, KRAS and BRAF in the MAPK pathway.
The mutant cells are engineered based on the HCT116 cancer cell line, in which mutations are integrated either homozygously or heterozygously using CRISPR technology. They can be used to enhance our understanding of cancer biology and the development of cancer therapies, either as cell line models for the study of metabolic and signalling pathways or as in vitro models for drug screening and toxicity studies.
The cell lines feature puromycin resistance for easy growth and maintenance. Mutations are available in both homozygous and heterozygous forms. Premade cell lines are available for next-day shipping; a custom cell line service is also available.
For more information: http://www.genecopoeia.com/product/cell-biology-product/cancer-mutant-cell-lines/.
Phone: 02 4575 0309
Hygiena foodproof Salmonella plus Cronobacter Detection LyoKit
Hygiena's foodproof Salmonella plus Cronobacter Detection LyoKit is an ISO...
Dojindo Laboratories ExoIsolator Exosome Isolation Kit
The ExoIsolator Exosome Isolation Kit, from Dojindo Laboratories, can collect exosomes...
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
Learn More
I am interested in GeneCopoeia OncoSpot Cancer Cell Lines.
Complete the form and a supplier representative will be in touch.
